Dnmt3/transcription factor interactions as crucial players in targeted DNA methylation

Epigenetic gene inactivation in mammalian cells involves many silencing mechanisms. One of these mechanisms is the transcriptional repression by targeted promoter hypermethylation. However, the molecular mechanisms involved in the site-specific DNA (hyper)methylation are not fully elucidate. By using the Dnmt3a/c-myc interaction as an example, we here showed that this interaction promotes the site-specific methylation of CG dinucleotides localized in c-myc boxes of promoter regions of CDKN2a, CCND1 and TIMP2 genes. Indeed, the invalidation of c-myc reveals that c-myc allows the Dnmt3a recruitment on c-myc box of c-myc-regulated genes. Acellular experiments corroborated and complemented these results by revealing that the specificity of consensus sequence for DNA methylation of Dnmt3a is increased in presence of c-myc. Indeed, our work indicates that Dnmt3a and Dnmt3b have consensus sequences to methylate DNA (T/A/C)(A/T)(T/G/A)CG(T/G/C)G(G/C/A) and (A/C)(C/G/A)(A/G)CGT(C/G)(A/G). Thus, the low specificity of these sequences (consensual for 162 and 48 possibilities, respectively) does not support the idea of targeted DNA methylation. By monitoring transcription factor arrays spotted with 103 transcription factors, we next identified 42 transcription factors interacting with Dnmt3a and Dnmt3b (such as CREB and FOS), 27 transcription factors interacting with Dnmt3a (such as AP2α and p53), 10 transcription factors interacting with Dnmt3b (such as SP1 and SP4), and 24 transcription factors devoid of direct interaction with Dnm3a and Dnmt3b (such as C/EBPα and NFκB-p65). Thus, The description of direct interaction between Dnmt3a and/or Dnmt3b and transcription factors provides rational molecular explanation to the mechanisms of targeted DNA (hyper)methylation, and to the mechanisms by which transcription factors repress genes expression.

[1]  Albert Jeltsch,et al.  Cyclical DNA methylation of a transcriptionally active promoter , 2008, Nature.

[2]  Peter A. Jones,et al.  Epigenetics in cancer. , 2010, Carcinogenesis.

[3]  P. Gluckman,et al.  DNMT3A and DNMT3B mediate autocrine hGH repression of plakoglobin gene transcription and consequent phenotypic conversion of mammary carcinoma cells , 2008, Oncogene.

[4]  L. Ricci-Vitiani,et al.  Loss of pericentromeric DNA methylation pattern in human glioblastoma is associated with altered DNA methyltransferases expression and involves the stem cell compartment , 2008, Oncogene.

[5]  W. Jones,et al.  DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines , 2008, Molecular Cancer.

[6]  M. Berger,et al.  Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma. , 2007, Neuro-oncology.

[7]  S. Pradhan,et al.  Molecular Mechanisms of Transactivation and Doxorubicin-mediated Repression of survivin Gene in Cancer Cells* , 2007, Journal of Biological Chemistry.

[8]  D. Tenen,et al.  Site-specific DNA methylation by a complex of PU.1 and Dnmt3a/b , 2006, Oncogene.

[9]  Lung-Ji Chang,et al.  CpG Sites Preferentially Methylated by Dnmt3a in Vivo* , 2006, Journal of Biological Chemistry.

[10]  Xiaoyu Zhang,et al.  Methylation of tRNAAsp by the DNA Methyltransferase Homolog Dnmt2 , 2006, Science.

[11]  Yaolin Wang,et al.  DNA methyltransferase-3a interacts with p53 and represses p53-mediated gene expression , 2005, Cancer biology & therapy.

[12]  T. Bestor,et al.  Eukaryotic cytosine methyltransferases. , 2005, Annual review of biochemistry.

[13]  M. Wasik,et al.  STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Jonathan E. Dodge,et al.  Inactivation of Dnmt3b in Mouse Embryonic Fibroblasts Results in DNA Hypomethylation, Chromosomal Instability, and Spontaneous Immortalization* , 2005, Journal of Biological Chemistry.

[15]  R. Mirimanoff,et al.  MGMT gene silencing and benefit from temozolomide in glioblastoma. , 2005, The New England journal of medicine.

[16]  T. Kouzarides,et al.  Myc represses transcription through recruitment of DNA methyltransferase corepressor , 2005, The EMBO journal.

[17]  K. Berns,et al.  Akt and 14-3-3η regulate Miz1 to control cell-cycle arrest after DNA damage , 2005, Nature Cell Biology.

[18]  A. Jeltsch,et al.  Biochemistry and biology of mammalian DNA methyltransferases , 2004, Cellular and Molecular Life Sciences CMLS.

[19]  E. Li,et al.  Preference of DNA methyltransferases for CpG islands in mouse embryonic stem cells. , 2004, Genome research.

[20]  J. McNally,et al.  Modification of de novo DNA methyltransferase 3a (Dnmt3a) by SUMO-1 modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcription. , 2004, Nucleic acids research.

[21]  K. Robertson,et al.  DMB (DNMT-magnetic beads) assay: measuring DNA methyltransferase activity in vitro. , 2004, Methods in molecular biology.

[22]  A. Jeltsch,et al.  The Human Dnmt2 Has Residual DNA-(Cytosine-C5) Methyltransferase Activity* , 2003, Journal of Biological Chemistry.

[23]  Martin Widschwendter,et al.  DNA methylation and breast carcinogenesis , 2002, Oncogene.

[24]  Bert Vogelstein,et al.  DNMT1 and DNMT3b cooperate to silence genes in human cancer cells , 2002, Nature.

[25]  P. Cartron,et al.  The expression of a new variant of the pro-apoptotic molecule Bax, Baxpsi, is correlated with an increased survival of glioblastoma multiforme patients. , 2002, Human molecular genetics.

[26]  C. Hsieh,et al.  Murine De Novo Methyltransferase Dnmt3a Demonstrates Strand Asymmetry and Site Preference in the Methylation of DNA In Vitro , 2002, Molecular and Cellular Biology.

[27]  Gangning Liang,et al.  Cooperativity between DNA Methyltransferases in the Maintenance Methylation of Repetitive Elements , 2002, Molecular and Cellular Biology.

[28]  M. Li,et al.  Characterization of the genomic structure and tissue-specific promoter of the human nuclear receptor NR5A2 (hB1F) gene. , 2001, Gene.

[29]  Scar,et al.  Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. , 2000, The New England journal of medicine.

[30]  C. Wijmenga,et al.  The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Silke Meyer,et al.  Compilation of vertebrate-encoded transcription factors , 1992, Nucleic Acids Res..